Drug industry in dire straits
News | 16 August 2012
Below are excerpts of a position paper by Emmanuel Mujuru, the chairperson of the Pharmaceutical Industry Association, prepared in October last year giving an overview on the state of the local pharmaceutical industry. The industry is reeling under low ...
Click on the link to read the full article at NewsDay
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
